SSICA - Stazione Sperimentale per l'Industria delle Conserve Alimentari, Parma, Italy.
The Tomato Foundation, Sitges, Spain.
Int J Food Sci Nutr. 2024 Feb;75(1):31-44. doi: 10.1080/09637486.2023.2270782. Epub 2023 Oct 23.
The aim of this study was to evaluate and compare the concentration of water-soluble bioactive compounds in tomato products (polyphenols profile, water-soluble vitamins and nucleophilic substances) with the concentration of the same bioactive molecules existing in a water-soluble patented tomato extract, water-soluble tomato extract (WSTC), commercially available as FruitFlow®. This patented tomato extract has been recognised by EFSA (European Food Safety Authority) in a specific Health Claim declaration as having an "Antiplatelet health effect". More than 100 commercial tomato samples, coming from 18 different processing tomato companies worldwide, were analysed and compared with the FruitFlow supplement. According to the multivariate statistical analyses applied to the data matrix, it is possible to conclude that the commercial tomato products measured (pastes, purees, others) show a significantly higher concentration of water-soluble bioactive molecules (nucleosides/nucleotides and polyphenols) responsible for an anti-platelet aggregation effect than the FruitFlow dietary supplement.
本研究旨在评估和比较番茄制品(多酚谱、水溶性维生素和亲核物质)中的水溶性生物活性化合物浓度与水溶性专利番茄提取物(水溶性番茄提取物,WSTC)中相同生物活性分子的浓度,WSTC 作为 FruitFlow®商业销售。这种专利番茄提取物已被 EFSA(欧洲食品安全局)在一项特定的健康声明中认可,具有“抗血小板健康效应”。对来自全球 18 家不同加工番茄公司的 100 多个商业番茄样本进行了分析,并与 FruitFlow 补充剂进行了比较。根据应用于数据矩阵的多变量统计分析,可以得出结论,所测量的商业番茄制品(糊剂、泥、其他)显示出更高浓度的水溶性生物活性分子(核苷/核苷酸和多酚),具有抗血小板聚集作用,高于 FruitFlow 膳食补充剂。